Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide-Assisted-Psychotherapy in Adults With Cannabis Use Disorder
NCT07671248Phase 3Not yet recruiting
- Sponsor
- McMaster University
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 3 trial of tirzepatide in cannabis use disorder (CUD), sponsored by McMaster University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT07671248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07671248.